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Background: Intravascular ultrasound (IVUS) determines the true morphologic severity of angiographic intermediate coronary lesions (ICL) which 
may be a useful guide for revascularisation. Long term outcomes based on IVUS guidance are limited. We sought to determine the clinical outcomes 
of patients with angiographic ICL who were referred for percutaneous intervention (PCI), coronary artery bypass graft surgery (CABGS) or medical 
therapy (MT) based on IVUS findings.
Methods: Between January 2006 to June 2009, 184 patients with angiographic ICL had IVUS performed. They were subsequently referred for PCI 
(n=43), CABG (n=73) or MT (n=85) based on IVUS findings. Clinical, angiographic and 2 year outcome data obtained from institutional database and 
telephone follow up were analysed. Composite endpoint include cardiac death, target vessel revascularization (TVR), congestive heart failure (CHF) 
or recurrent angina requiring admission.
Results: In the PCI, CABG and MT groups, there was no significant difference in baseline characteristics including age (61 vs 65 vs 61years), gender 
(55% vs 69% vs 61% male) and risk factors including hypertension (48% vs 62% vs 58%), hyperlipidemia (57% vs 60% vs 41%), smoking (37% vs 
30% vs 38%) and diabetes (24% vs 16% vs 13%). The incidence of angiographic multi-vessel disease was significantly higher in the CABG group 
compared against both the PCI and MT groups (p<0.0001). No difference was observed in the composite endpoint (16% vs 8% vs 17%), mortality 
(5% vs 7% vs 2%), recurrent angina requiring admission (7% vs 4% vs 8%) and CHF (5% vs 2% vs 4%) in the PCI, CABG and MT groups respectively. 
The need for revascularisation (2% vs 0% vs 6%) was significantly higher in the MT group (p=0.03) compared with CABG but not against PCI group 
(p=0.37).
Conclusion: Management of angiographic intermediate coronary lesions guided by IVUS findings results in comparable long term clinical 
outcomes in patients referred for PCI, CABGS or medical therapy. 
